• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESPIRONICS, INC. DREAMSTATION CPAP PRO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESPIRONICS, INC. DREAMSTATION CPAP PRO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number CAX400T12
Medical Device Problem Code Degraded (1153)
Health Effect - Clinical Codes Dyspnea (1816); Hydrocephalus (3272); Unspecified Respiratory Problem (4464); Skin Inflammation/ Irritation (4545)
Date of Event 07/12/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H3 other text : device not returned to manufacturer.
 
Event or Problem Description
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging an issue related to a dreamstation cpap pro device's sound abatement foam.The patient alleges having skin irritation started last year, shortness of breath, cephalus and sinus congestion.Medical intervention was not specified.The patient was advised by the doctor to change her unit immediately.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
 
Additional Manufacturer Narrative
The manufacturer was previously contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging an issue related to a dreamstation cpap pro device's sound abatement foam.The patient alleges having skin irritation started last year, shortness of breath, cephalus and sinus congestion.Medical intervention was not specified.The patient was advised by the doctor to change her unit immediately.In box b: adverse event/product problem, outcomes attributed to ae are updated in this follow-up.The updated describe event or problem will be: the manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging with skin irritation started last year, shortness of breath, cephalus and sinus congestion.There was no serious patient harm or injury.No medical intervention was specified by the patient.No additional information can be requested at this time.The manufacturer was made aware of this complaint through a representative of the customer.At this time, no further investigation can be performed.If any additional information is received, a follow up report will be filed.In box d: product udi is updated in this follow-up.In box h: type of reported complaint, health impact grid are updated in this follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DREAMSTATION CPAP PRO
Common Device Name
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
RESPIRONICS, INC.
1001 murry ridge lane
murrysville PA 15668
Manufacturer (Section G)
RESPIRONICS, INC.
1001 murry ridge lane
murrysville PA 15668
Manufacturer Contact
melissa rosko
6501 living place
pittsburgh, PA 15208
4125423300
MDR Report Key18131686
Report Number2518422-2023-29993
Device Sequence Number7790524
Product Code BZD
UDI-Device Identifier00606959026575
UDI-Public(01)00606959026575
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K131982
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 01/06/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberCAX400T12
Device Catalogue NumberCAX400T12
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/12/2021
Supplement Date Received by Manufacturer07/12/2021
Initial Report FDA Received Date11/14/2023
Supplement Report FDA Received Date01/06/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/05/2018
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1974-2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-